Received Mar 4, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| PPV | PNEUMO (PNEUMOVAX) | MERCK & CO. INC. | UNK | X018278 | — |
not experienced any ill effects; Expired Pneumovax 23 was administered; This spontaneous report was received from an other healthcare profession via vendor and refers to a 72-year-old female patient. No information regarding the patient's medical history, concurrent conditions, concomitant medications, drug reactions or allergies was provided. On 12-FEB-2025, the patient was vaccinated with an expired dose of Pneumococcal Vaccine, Polyvalent (23-valent) (PNEUMOVAX 23) lot # X018278 was confirmed to be valid, expiration date 24-NOV-2024, for prophylaxis (dose, route and site of administration were not reported). The patient had no ill effects.